Showing results (151-160 of 174) with videos related to
Sort By:
Pageof 18
The Laryngoscope|November 4, 2015
Using Lean Thinking at an otorhinolaryngology outpatient clinic to improve quality of careJanneke E van Leijen-Zeelenberg, Jan Wouter Brunings, Inge Houkes, et al.Journal of Electrocardiology|February 13, 1999
Integration and communication for the continuity of cardiac care (I4C)J H van Bemmel, A M van Ginneken, H Stam, et al.BMC Health Services Research|January 20, 2016
The impact of redesigning care processes on quality of care: a systematic reviewJanneke E van Leijen-Zeelenberg, Arianne M J Elissen, Kerstin Grube, et al.Molecular Pharmaceutics|October 8, 2014
Tracking targeted bimodal nanovaccines: immune responses and routing in cells, tissue, and whole organismLuis J Cruz, Paul J Tacken, Ingrid S Zeelenberg, et al.Cancer Immunology, Immunotherapy : CII|February 18, 2015
Intra-adrenal murine TH-MYCN neuroblastoma tumors grow more aggressive and exhibit a distinct tumor microenvironment relative to their subcutaneous equivalentsMichiel Kroesen, Ingrid C Brok, Daphne Reijnen, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 1, 1989
Noninvasive axial and peripheral assessment of bone mineral content: a comparison between osteoporotic women and normal subjectsF N Van Berkum, J C Birkenhäger, L C Van Veen, et al.Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 1, 1995
Effects of 24R,25-dihydroxyvitamin D3 in combination with 1 alpha-hydroxyvitamin D3 in predialysis renal insufficiency: biochemistry and histomorphometry of cancellous boneD H Birkenhäger-Frenkel, H A Pols, J Zeelenberg, et al.Cancer Research|February 19, 2008
Targeting tumor antigens to secreted membrane vesicles in vivo induces efficient antitumor immune responsesIngrid S Zeelenberg, Matias Ostrowski, Sophie Krumeich, et al.Blood|July 9, 1999
The FcgammaRIa (CD64) ligand binding chain triggers major histocompatibility complex class II antigen presentation independently of its associated FcR gamma-chainM J van Vugt, M J Kleijmeer, T Keler, et al.Blood|October 5, 2011
Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticityPaul J Tacken, Ingrid S Zeelenberg, Luis J Cruz, et al.Pageof 18